# Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve Outcomes

> **NCT05734729** · NA · UNKNOWN · sponsor: **Changi General Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Pleural Effusion
- Ascites

## Interventions

- **DEVICE:** EFFIDRAIN
- **DEVICE:** Manual drainage system

## Key facts

- **NCT ID:** NCT05734729
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-27
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734729, "Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve Outcomes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05734729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*